Failure to Diagnose Cancer: Calculating Loss of Chance Damages

Published 2026-05-27 · John Mahoney · MedLegal AI

The hardest cancer malpractice cases are not the ones where the patient definitely would have lived with timely diagnosis. Those are easy — full damages, traditional causation analysis. The hard cases are the ones where the cancer was probably going to kill the patient regardless, and the delayed diagnosis just reduced the chance of survival from, say, 60% to 30%. Traditional but-for causation says: more likely than not the patient would have died anyway, so no recovery.

Loss of chance doctrine fixes this. About 25 states recognize loss of chance in some form. In those jurisdictions, the patient's reduced survival probability is itself compensable. This guide covers how to identify the doctrine in your jurisdiction, calculate the damages, and prove causation in cases where pure but-for causation would lose.

What Loss of Chance Is

Loss of chance allows recovery when negligence reduces the probability of a favorable outcome, even if the patient probably would have had the bad outcome anyway. Three main variations:

Pure loss of chance (Massachusetts, Oklahoma, Indiana)

Damages equal the full damages multiplied by the percentage of survival probability lost. If the patient had a 60% chance of survival with timely diagnosis and a 30% chance with delayed diagnosis, the lost chance is 30%. Full wrongful death damages are calculated, then multiplied by 30% to get the actual recoverable amount.

Increased risk of harm (Pennsylvania, New Jersey)

Plaintiff must prove that the negligence "increased the risk of harm" and that the increased risk was a substantial factor in causing the eventual harm. Full damages are then recoverable if substantial-factor causation is met. This is more plaintiff-friendly than pure loss of chance.

Substantial possibility (Washington, others)

Plaintiff must prove a "substantial possibility" (less than 50%) of survival was lost. If proven, full damages recoverable. Substantial possibility is typically defined as somewhere between 10% and 50%.

Jurisdictions That Recognize Loss of Chance

States that have adopted loss of chance in some form (verify current law in your jurisdiction):

• Arizona, Connecticut, Florida (limited), Georgia (limited), Illinois
• Indiana, Iowa, Kansas, Louisiana, Massachusetts
• Michigan, Missouri, Nevada, New Hampshire, New Jersey
• New Mexico, Ohio, Oklahoma, Oregon, Pennsylvania
• South Dakota, Tennessee, Vermont, Washington, West Virginia, Wisconsin, Wyoming

States that have rejected loss of chance (also verify):

• Alabama, California (modified), Florida (strict in some contexts), Idaho
• Maryland, Minnesota, Mississippi, South Carolina, Tennessee (split), Texas, Vermont (split)

The recognition trend has been toward acceptance, but the specific doctrinal formulation varies. Pre-litigation, identify your specific jurisdiction's rule.

The Stage Migration Analysis

The core of a delayed-diagnosis cancer case is stage migration: the patient's cancer was at an earlier stage when it should have been diagnosed, and progressed to a later stage by the time it was actually diagnosed.

Stage migration analysis requires:

1. Date of negligence: when should the diagnosis have been made? (typically the date a normal physician would have ordered the diagnostic study that caught the cancer)
2. Date of actual diagnosis: the documented date
3. Estimated stage at date of negligence: requires expert oncology testimony, often based on growth-rate calculations from cancer-specific literature
4. Actual stage at diagnosis: from the pathology report
5. 5-year survival at stage of negligence: from SEER (Surveillance, Epidemiology, and End Results) or cancer-specific registries
6. 5-year survival at actual stage: from same sources

The difference between the two 5-year survival rates is the lost chance.

Common Failure-to-Diagnose Cancer Scenarios

Mammography misread

Radiologist misreads suspicious finding on mammogram as benign. Patient is reassured. Cancer progresses 1-3 years until next mammogram catches it. Stage at delayed diagnosis is typically 2-3 stages higher than at the missed-finding date.

Pap smear misread or untimely follow-up

Cytotechnologist or pathologist misses dysplastic cells. Cervical cancer progresses to invasive disease. Stage migration from CIN 2/3 to invasive cancer represents substantial loss of chance.

PSA + DRE not performed timely

Primary care fails to order PSA or DRE per USPSTF or specialty society guidelines. Prostate cancer presents with metastatic disease that would have been organ-confined with timely screening.

Colon cancer missed on colonoscopy

Gastroenterologist misses lesion or fails to perform adequate prep/withdrawal. Cancer progresses from polyp to invasive disease. Loss of chance frequently substantial.

Lung nodule on chest CT missed

Radiologist reports incidental nodule but does not flag for follow-up, or follow-up is not arranged. Lung cancer progresses from Stage 1 to Stage 3-4 over 1-3 years.

Pediatric cancer presenting as benign symptoms

Symptoms attributed to growing pains, viral illness, or anxiety when actually leukemia, lymphoma, or solid tumor. Pediatric cases support both standard causation (typically more recoverable) and loss-of-chance frameworks.

Expert Witnesses Required

Cancer loss-of-chance cases typically require multiple experts:

• Specialty expert (e.g., breast surgeon, oncologist): establishes the standard of care for the screening or diagnostic study
• Pathologist: interprets the missed finding and the actual finding
• Oncologist: establishes the stage migration and 5-year survival differential
• Biostatistician (sometimes): validates the survival data and the lost-chance calculation
• Life-care planner: for survival cases with ongoing treatment costs
• Forensic economist: for wrongful death and economic damages

Discovery Targets

• Complete medical record from the date of negligence through diagnosis
• All imaging studies and pathology slides (often need to be re-read by your expert)
• Hospital's screening compliance audits for the relevant timeframe
• Radiologist's or pathologist's read history (quality assurance data)
• Manufacturer's data on the imaging device used (calibration, software version)
• Prior similar misses by the same provider or facility
• Tumor registry data for the patient's cancer type

Damages Structure

In pure loss-of-chance jurisdictions:

Recoverable damages = Full damages × (probability of survival with timely diagnosis − probability of survival with actual diagnosis)

Example: Patient with breast cancer at 55. Expected 5-year survival at Stage 1: 99%. Stage 3B at diagnosis: 72%. Lost chance: 27%. Full wrongful death damages: $4M. Recoverable: $4M × 27% = $1.08M.

In substantial-factor jurisdictions (NJ, PA): full $4M may be recoverable if the increased risk was a substantial factor in causing death.

Why These Cases Settle

Defense counsel knows loss-of-chance damages are calculable and predictable. Once you've established stage migration with expert testimony and survival differential from published data, the case has a defined value range. Carriers prefer to settle within that range rather than risk a sympathetic jury awarding higher amounts (or worse, full damages under a substantial-factor theory).

The cases that don't settle are typically the ones where the stage migration is disputed (defense expert says cancer progresses faster than yours says it does) or where the standard of care for the missed screening is contested.

Related: missed cancer diagnosis, wrongful death case strategy, settlement negotiation.